BSX vs SSP · P/E 20, rev $10.65B vs rev $1.01B
Boston Scientific Corp (BSX) versus E. W. Scripps Co Class A (SSP) — a side-by-side from cached financials, not a winner call.
Boston Scientific Corp (BSX) is a medical devices company listed on US.
E. W. Scripps Co Class A (SSP) is a broadcasting company listed on US.
Latest reported BSX revenue for 2026-06-30 was $10.65B. Net income was $2.24B. BSX currently screens at market cap $71.81B and trailing P/E 20.2.
Latest reported SSP revenue for 2026-06-30 was $1.01B. Net income was -$1.15B. Revenue was up 94.9% from 2026-03-31 to 2026-06-30. SSP currently screens at market cap $312.2M.
BSX currently screens at market cap $71.81B and trailing P/E 20.2. SSP currently screens at market cap $312.2M.
Not investment advice. Open the BSX and SSP stock pages for the full models.
Not investment advice.